Active and indolent chronic lymphocytic leukaemia - immune and hormonal peculiarities

被引:9
作者
Everaus, H
Luik, E
Lehtmaa, J
机构
[1] Department of Internal Medicine, University of Tartu, Tartu EE2400
关键词
chronic lymphocytic leukaemia; active/indolent; immune status; endocrine hormones;
D O I
10.1007/s002620050409
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A group of 138 B cell chronic lymphocytic leukaemia (B-CLL) patients, 83 with active disease and 53 having the indolent form of the disease, were evaluated. The aim of the study was to clarify whether indolent and active B-CLL differ in their immune and hormonal characteristics. Peripheral blood lymphocyte proliferation in response to phytohaemagglutinin, concanavalin A, recombinant interleukin-2, dextran sulphate, Pisum sativatum agglutinin and wheat germ agglutinin was investigated. Serum immunoglobulin and beta(2) microglobulin levels were determined. Adrenocorticotropic hormone (ACTH), cortisol, follicle-stimulating hormone luteinizing hormone, 17-beta-oestradiol, testosterone, triiodothyronine, thyroxine, thyroglobulin and thyrotropic hormone levels were determined by radioimmunoassay. Active and indolent CLL presented differences in immunological characteristics, as demonstrated by the more severe suppression of T lymphocyte function, reduced IgA level and considerably higher serum beta 2-microglobulin values in active disease. Immune disturbances were accompanied by hormonal imbalance, depend ing on disease status: lower ACTH, cortisol and triiodothyronine levels were established to occur in active CLL compared to indolent disease. Male patients demonstrated striking changes in sex hormones, which were more evident in active disease. The findings point to the complexity of immune-hormonal disturbances in CLL with differences in the active and indolent state of the disease.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 46 条
[31]  
KORSMEYER SI, 1983, P NATL ACAD SCI USA, V80, P3844
[32]   INTERLEUKIN 2-INDUCED PROLIFERATION OF LEUKEMIC HUMAN B-CELLS [J].
LANTZ, O ;
GRILLOTCOURVALIN, C ;
SCHMITT, C ;
FERMAND, JP ;
BROUET, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (05) :1225-1230
[33]   PROGNOSTIC VALUE OF SERUM BETA-2 MICROGLOBULIN IN LOW-GRADE LYMPHOMA [J].
LITAM, P ;
SWAN, F ;
CABANILLAS, F ;
TUCKER, SL ;
MCLAUGHLIN, P ;
HAGEMEISTER, FB ;
RODRIGUEZ, MA ;
VELASQUEZ, WS .
ANNALS OF INTERNAL MEDICINE, 1991, 114 (10) :855-860
[34]  
Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2
[35]  
MONTSERRAT E, 1989, ANN INTERN MED, V110, P236
[36]  
MORABITO F, 1995, LEUKEMIA, V9, P1450
[37]  
MOZZANA LBR, 1985, BLOOD, V65, P340
[38]   TRANS-MEMBRANE CONTROL OF RECEPTORS ON NORMAL AND TUMOR-CELLS .2. SURFACE CHANGES ASSOCIATED WITH TRANSFORMATION AND MALIGNANCY [J].
NICOLSON, GL .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 458 (01) :1-72
[39]  
PANAYOTIDES P, 1986, MED ONCOL TUMOR PHAR, V3, P255
[40]  
PLATSOUCAS CD, 1982, J IMMUNOL, V129, P2305